FacebookTwitterGoogle+RedditEmail

The Anthrax Chronicles

by Steve Perry

The U.S. Congress headed for the hills on Wednesday after it was reported that the anthrax sample received at Senator Tom Daschle’s office on Monday may have gotten into the ventilation system of the Senate’s Hart Office Building. By mid-morning Wednesday some 29 Daschle staffers had already tested positive for exposure to anthrax, and hundreds of others Capitol Hill staffers were standing in line to get nasal swabs. House Speaker Dennis Hastert announced that House offices would close until at least next Tuesday, and the Senate was expected to follow suit. Congress is effectively closed until the middle of next week. Around mid-day came word that spores had also been found in offices of New York Governor George Pataki.

 

Despite the innumerable official-sounding speculations, no one knows where the anthrax originated or what it may bode for the future. The Daschle mailing, like the letter sent to NBC’s Tom Brokaw, was postmarked in Trenton, New Jersey. But if official accounts are to be believed, the spores contained in the Daschle letter were enormously more potent than any of the other anthrax samples seen to date. Televised CNN reports made ambiguous reference to the possibility that the Florida and D.C. anthrax mailings came from “different groupings,” but it wasn’t clear whether that meant they represented different strains of the bacteria, or just that they had been processed at separate facilities by different means. In either case it underlined the relative ease of acquiring and transporting anthrax bacteria. Processing the spores into “weapons-grade” packages containing spores of 1 to 10 microns in size may be a sophisticated procedure, but acquiring the raw materials was simple as could be until very recently-and there’s no telling how long the perpetrators have possessed it or how they got it.

These matters aside, there’s no denying that the use of the U.S. Postal Service was a stroke of brilliance on the part of the perpetrators. It’s a virtually untraceable delivery system (investigators pursuing the Trenton connection admitted on Tuesday that the mailing to Daschle’s office might have come from any of 46 different postal branches, and probably did not come from a resident of Trenton) that maximizes the element of fear and paralysis and makes the most of what may-or may not-be limited supplies of the bacilli. It likewise circumvents the problem of coordination and possible detection associated with a more public release of anthrax spores. The perpetrators have succeeded in creating the impression they can go anywhere: The sites infiltrated in the past few days include two major media networks, a titan of American capitalism-the Microsoft offices in Reno, Nevada-and two prominent state and federal government facilities.

Cipro: Public health vs. corporate patents

Meanwhile the patent lawyers fiddle as Rome smolders. Bayer AG, the German pharmaceutical company that holds the patent on Cipro, the antibiotic of choice in treating anthrax exposure, is working round the clock to stave off international calls for the violation of its copyright in the interest of public health. On Tuesday New York Senator Charles “Boomer” Schumer joined the chorus calling for the broad-scale licensing of generic manufacturing of Cipro clones to combat the prospective rise in anthrax exposure. Bayer responded by promising to ramp up its production of Cipro from 15 to 60 million tablets per month. Even at that level, the stores of Cipro would be sufficient to treat only half a million exposures-and scares-around the world, since the preventative course of Cipro involves two tablets daily for 60 days. This is not to mention the cost factor: Under patent protections, Cipro presently costs $350 a month in the United States, but according to the New York Times, the same formula from “reputable suppliers” costs only $10 a month in India.

But set aside the cost and consider the broader ramifications. Capacity for treating half a million may seem a lot, but it’s a paltry sum from a public health standpoint given the rapidly escalating number of anthrax threats in the U.S. alone. The Schumer proposal is entirely sensible and prudent, and his office notes that at least three other drug manufacturers could be flooding the market with generic Cipro substitutes within two to three months if given the go-ahead. But the Bush administration’s Department of Health and Human Services is so far on the side of corporate patents. Said HHS flak Kevin Keane on Tuesday: “We’ll certainly take a look at the senator’s proposal, but we don’t see the need right now. Right now we have enough Cipro and other antibiotics for the contingencies before the American public. If we have an emergency, the manufacturers can turn this around quickly. We have to be careful about patent protections-there’s a balance there.”

As the Wednesday New York Times feature makes clear, there are provisions in U.S. law that allow the government to ignore any drug patent with impunity and allow competitors to make a generic equivalent. But so far the Bush administration is loath to do so. For one they are worried that any invocation of a national emergency to violate the Bayer patent on Cipro would set a dangerous precedent for the release of patented AIDS drugs in Africa. Many of the drugs in question are of course patented by American drug companies. National crises come and go, but business is business. CP

Steve Perry writes frequently for CounterPunch and is a contributor to the excellent cursor.org website, which offers incisive coverage of the current crisis. He lives in Minneapolis, MN.

More articles by:

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

June 29, 2017
Dave Lindorff
Sy Hersh, Exposer of My Lai and Abu Ghraib, Strikes Again, Exposing US Lies About Alleged Assad Sarin ‘Attack’
Chuck Collins
What Happened to America’s Wealth? The Rich Hid It
Rev. William Alberts
When the Bible is the Root of Evil
Jeff Mackler
Trumps ‘No Fly Zone’ Escalates U.S. War Against Syria
Bill Willers
The Next World War Won’t Just Be “Over There” 
Ellen Brown
Sovereign Debt Jubilee, Japanese-Style
Jack Laun
Will There Finally be Peace With Justice in Colombia?
Binoy Kampmark
Holding the Police to Account in the UK
David Swanson
Against Ignoring the KKK
Rima Najjar
Israel’s Illegitimate Tactics Against Palestinian Armed Resistance vs. Legitimate Global Security Concerns
Mel Gurtov
Advise, Assist, Arm: The United States at War
David Welsh
Berkeley Capitulates to Police Militarization and Spying
Marion Andrew
Not Being Considerate of One’s Audience: US Television’s Coverage of Olympic and International Sports
June 28, 2017
Diana Johnstone
Macron’s Mission: Save the European Union From Itself
Jordon Kraemer
The Cultural Anxiety of the White Middle Class
Vijay Prashad
Modi and Trump: When the Titans of Hate Politics Meet
Jonathan Cook
Israel’s Efforts to Hide Palestinians From View No Longer Fools Young American Jews
Ron Jacobs
Gonna’ Have to Face It, You’re Addicted to War
Jim Lobe – Giulia McDonnell Nieto Del Rio
Is Trump Blundering Into the Next Middle East War?
Radical Washtenaw
David Ware, Killed By Police: a Vindication
John W. Whitehead
The Age of No Privacy: the Surveillance State Shifts into High Gear
Robert Mejia, Kay Beckermann and Curtis Sullivan
The Racial Politics of the Left’s Political Nostalgia
Tom H. Hastings
Courting Each Other
Winslow Myers
“A Decent Respect for the Opinions of Mankind”
Leonard Peltier
The Struggle is Never for Nothing
Jonathan Latham
Illegal GE Bacteria Detected in an Animal Feed Supplement
Deborah James
State of Play in the WTO: Toward the 11th Ministerial in Argentina
Andrew Stewart
Health Care for All: Why I Occupied Sen. Sheldon Whitehouse’s Office
Binoy Kampmark
The European Commission, Google and Anti-Competition
Jesse Jackson
A Savage Health Care Bill
Jimmy Centeno
Cats and Meows in L.A.
June 27, 2017
Jim Kavanagh
California Scheming: Democrats Betray Single-Payer Again
Jonathan Cook
Hersh’s New Syria Revelations Buried From View
Edward Hunt
Excessive and Avoidable Harm in Yemen
Howard Lisnoff
The Death of Democracy Both Here and Abroad and All Those Colorful Sneakers
Gary Leupp
Immanuel Kant on Electoral Interference
Kenneth Surin
Theresa May and the Tories are in Freefall
Slavoj Zizek
Get the Left
Robert Fisk
Saudi Arabia Wants to Reduce Qatar to a Vassal State
Ralph Nader
Driverless Cars: Hype, Hubris and Distractions
Rima Najjar
Palestinians Are Seeking Justice in Jerusalem – Not an Abusive Life-Long Mate
Norman Solomon
Is ‘Russiagate’ Collapsing as a Political Strategy?
Binoy Kampmark
In the Twitter Building: Tech Incubators and Altering Perceptions
Dean Baker
Uber’s Repudiation is the Moment for the U.S. to Finally Start Regulating the So-called Sharing Economy
Rob Seimetz
What I Saw From The Law
FacebookTwitterGoogle+RedditEmail